arginine has been researched along with Vaginitis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bai, X; Chen, Y; Jin, L; Lai, R; Liu, W; Lu, Q; Luan, N; Rong, M; Yan, X; Yao, H; Zhang, Z | 1 |
Arakawa, T; Ikeda, K; Irie, H; Koyama, AH; Minami, S; Sekino, Y; Suzuki, Y; Tsujimoto, K; Yamasaki, H | 1 |
2 other study(ies) available for arginine and Vaginitis
Article | Year |
---|---|
A Designed Tryptophan- and Lysine/Arginine-Rich Antimicrobial Peptide with Therapeutic Potential for Clinical Antibiotic-Resistant Candida albicans Vaginitis.
Topics: Animals; Antimicrobial Cationic Peptides; Arginine; Candida albicans; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Fungal; Female; HEK293 Cells; Hemolysis; Humans; Lysine; Mice; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tryptophan; Vaginitis | 2016 |
Arginine inactivates human herpesvirus 2 and inhibits genital herpesvirus infection.
Topics: Administration, Intravaginal; Animals; Antiviral Agents; Arginine; Chlorocebus aethiops; Drug Evaluation, Preclinical; Female; Herpes Genitalis; Herpesvirus 2, Human; Humans; Hydrogen-Ion Concentration; Mice; Mice, Inbred BALB C; Vaginitis; Vero Cells; Viral Load; Virus Replication | 2012 |